A platform for success
From drug discovery to commercialization.
OUR MISSION
To be the leading Integrated Product Development and Market Access platform for better patient outcomes.
Who we are
A platform for success
Built upon the strong foundation of delivering decades of industry-leading regulatory and quality services, G&L Scientific (G&L) has evolved into a leading Integrated Product Development and Market Access Platform, delivering positive outcomes to patients through a strategic combination of organic growth, strategic partnership and acquisitions.
Harnessing global expertise and innovation, G&L is expertly positioned to support the pharmaceutical, biopharmaceutical, and biotechnology industries as they undergo a scientific renaissance.
We aim to provide a single, unified source of best-in-class solutions across the entire product pipeline; from drug and clinical development, agency interactions and regulatory submissions through to product approval, market access, quality and compliance, business transformation and beyond.
We are dedicated to guiding and supporting our clients to success and maximizing the value of their assets for the ultimate benefit of patients worldwide.
OUR SERVICES
Discover how we can help you
Scalable solutions and expert intelligence
G&L Scientific provides high-quality, value-driven, specialist Regulatory Affairs and Quality Assurance services for small, medium and large pharmaceutical and life sciences organizations.
Combining global scalability with deep technical expertise, our expertise spans CMC, ATMPs, Clinical and Market Access across 100+ global markets.
As a winner of the Queen’s Award for Enterprise 2022 and the King’s Award for Enterprise 2024, we offer a proven alternative to traditional CROs through a flexible Functional Service Provider (FSP) model that reduces operational overhead and accelerates submission timelines.
Our extensive network covers over 100 global markets, ensuring that CMC, clinical, and post-approval strategies are informed by local intelligence and executed with first-cycle approval as the primary objective.
Why choose G&L Scientific?
| Feature | G&L Scientific | Traditional CRO/Staffing |
| Delivery Model | Flexible FSP & Managed Teams | High-overhead FSO or individual contractors |
| Global Reach | Local expertise in 100+ markets | Often limited to major hubs (US/EU) |
| Speed to Scale | 7-14 days (via The Source platform) | 4-8 weeks average |
| Specialisms | CMC, ATMPs, HTA & Evidence Strategy, Market Access | Generalist regulatory support |
| Recognition | Queen's Award for Enterprise 2022
King's Award for Enterprise 2024 | Standard industry certifications |
TESTIMONIALS
What our clients say...
Latest Thinking
Blog
Revisit: EMA guideline on active substances - what changed at final adoption
With new rules coming into force on 1 September 2026, Rachael O'Kane examines what has changed and where companies need to act.
Read MoreWork With US
Want to be a part of something great?
Are you ready to design and deliver solutions that drive better patient outcomes?
We are on a mission to build a better tomorrow for everyone.
Could you play an integral role at G&L?